Yishen Mao

Yishen Mao

Auto-generated profile, based on publicly available information

Yishen Mao

Department of Pancreatic Surgery, Huashan Hospital, Fudan University, Shanghai200040, China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Chinese Chemical Letters
Verified
Journal Article
Closed access
YMYishen Mao
Yishen Mao
CZCaifeng Zou
Caifeng Zou
YJYongjian Jiang
Yongjian Jiang
DFDeliang Fu
Deliang Fu

26 December 2018 in Cancer Genomics & Proteomics
Verified
Journal Article
Closed access
PDF file
HLHengchao Li
Hengchao Li
YMYishen Mao
Yishen Mao
YXYueting Xiong
Yueting Xiong
HZHuan Huan Zhao
Huan Huan Zhao
FSFenglin Shen
Fenglin Shen
DFDeliang Fu
Deliang Fu
Background/Aim: Pancreatic cancer (PC) is currently the fourth leading cause of cancer-related mortality worldwide. Peripheral blood mononuclear cells (PBMCs) is a subpopulation of accessible and functional immune cells. Comparative analysis of the proteome of PBMCs can help us elucidate the mechanism of disease and find potential biomarkers for diagnosis. Materials and Methods: PBMCs were collected from healthy individuals, patients with benign diseases, and pancreatic cancer. iTRAQ-2DLC-MS/MS and SWATH methodologies were applied to make a comparative proteomics analysis of PBMCs. Results: A total of 3,357 proteins with a false discovery rate (FDR) <1% were identified, of which 114 proteins were found dysregulated in the PC group. An extensive SWATH library was constructed which showed a potential application for large scale clinical sample analysis. Conclusion: A PBMCs proteome with extensive protein representation was achieved, which will potentially allow the identification of novel biomarkers for PC.

29 June 2020 in British Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
YMYi-Shen Mao
Yi-Shen Mao
SHSi-Jie Hao
Si-Jie Hao
CZCai-Feng Zou
Cai-Feng Zou
ZXZhi-Bo Xie
Zhi-Bo Xie
DFDe-Liang Fu
De-Liang Fu
Preoperative nutritional status plays an important role in predicting postoperative outcomes. Prognostic Nutritional Index (PNI) and Controlling Nutritional Status (CONUT) are good tools to assess patients’ nutritional status. They have been used in predicting outcomes in various malignancies, but few studies have focused on pancreatic adenocarcinoma (PDAC) patients. Totally, 306 PDAC patients were enrolled. The propensity score matching (PSM) method was introduced to eliminate the baseline inequivalence. Patients with different PNI (or CONUT) scores showed inequivalence baseline characteristics, and patients with compromised nutritional status were related with a more advanced tumour stage. After PSM, the baseline characteristics were well balanced. Both low PNI (≤45) and high CONUT (≥3) were independent risk factors for poor overall survival (P < 0·05), and the result remained the same after PSM. Survival analysis demonstrated both patients with low PNI and high CONUT score were associated with poorer survival, and the result remained the same after PSM. The results of AUC indicated that CONUT might have a higher sensitivity and specificity in predicting complications and survival. Preoperative low PNI (≤45) and high CONUT (≥3) scores might be reliable predictors of prognosis and surgical complications in PDAC patients. Compared with PNI, CONUT might be more effective.